
Recent Articles
This Novavax Stock Pullback May Be a Massive Opportunity
By
Todd Shriber, InvestorPlace Contributor
With biotech companies, regardless of what drug, therapy or vaccine being worked on, clinical trials are vital and that's certainly the case with NVX-CoV2373 stepping into the second stage. This trial is relevant because it will include testing on humans in age groups deemed highly susceptible to contracting Covid-19 and dying from the illness.
3 Household Stocks to Clean Up With
By
Todd Shriber, InvestorPlace Contributor
Investors looking for low beta coronavirus plays with decent dividend yields should consider household stocks.
With Linear TV on Life Support, Roku Is Alive and Kicking
By
Todd Shriber, InvestorPlace Contributor
Roku stock is winning the streaming platform battle and with streaming beating linear TV, there's potential for big gains here.
Nikola Has Big EV Potential, But Don’t Measure It Against Tesla
By
Todd Shriber, InvestorPlace Contributor
Hydrogen is why Nikola focuses on trucks. Sleek as some EVs are, say a Tesla Model 3, they aren't large enough to carry bulky hydrogen tanks. Pickups and trucks for industrial, however, can accommodate those tanks.
Taoping Isn’t the Chinese Stock to Embrace
By
Todd Shriber, InvestorPlace Contributor
Taoping stock is a mess and things could get worse because the company isn't really capturing much of China's growing cloud market.

Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.